Interventional Oncology Devices Market

By Product;

Embolization Devices, Ablation Devices, and Support Devices

By Procedure;

Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), or Selective Internal Radiation Therapy (SIRT), and Transcatheter Arterial Embolization (TAE), or Bland Embolization

By Cancer Type;

Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, and Others

By End Use;

Hospitals, Ambulatory Surgical Centers, and Cancer Research Institutes

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn152431252 Published Date: August, 2025

Interventional Oncology Devices Market Overview

Interventional Oncology Devices Market (USD Million)

Interventional Oncology Devices Market was valued at USD 2,424.99 million in the year 2024. The size of this market is expected to increase to USD 4,577.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.5%.


Interventional Oncology Devices Market

*Market size in USD million

CAGR 9.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.5 %
Market Size (2024)USD 2,424.99 Million
Market Size (2031)USD 4,577.29 Million
Market ConcentrationMedium
Report Pages392
2,424.99
2024
4,577.29
2031

Major Players

  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Merit Medical Systems, Inc
  • Philips Volcano

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Interventional Oncology Devices Market

Fragmented - Highly competitive market without dominant players


The Interventional Oncology Devices Market is transforming cancer care with targeted and minimally invasive treatment options. Adoption of interventional oncology techniques has increased by over 48%, as procedures such as ablation, embolization, and biopsy provide precision therapies with fewer side effects. These solutions are reshaping oncology by offering safer and more patient-friendly alternatives to traditional methods.

Key Drivers Accelerating Growth
The rising burden of cancer cases and the need for less invasive therapies are fueling demand for interventional oncology devices. Research shows that nearly 63% of patients treated with these techniques experience faster recovery compared to conventional surgery. Reduced hospital stays and improved patient comfort are strengthening their adoption in oncology practices.

Advancements Strengthening Market Adoption
Technological progress in image-guided systems, ablation technologies, and embolic materials is enhancing safety and precision. Around 52% of specialists recommend interventional oncology devices for suitable cases, while 41% of patients report improved post-treatment quality of life. These advancements are driving wider clinical acceptance and long-term trust.

Growth Prospects and Industry Outlook
The Interventional Oncology Devices Market shows strong growth potential, supported by rising adoption of minimally invasive solutions. More than 66% of healthcare stakeholders identify these devices as essential to the future of oncology care. Continued R&D and broader integration into cancer treatment strategies will solidify their role in advancing safe, effective, and patient-centered care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Procedure
    3. Market Snapshot, By Cancer Type
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Interventional Oncology Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Cancer
        2. Technological Advancements
        3. Growing Preference for Minimally Invasive Procedures
      2. Restraints
        1. High Cost of Interventional Oncology Procedures
        2. Stringent Regulatory Approval Process
        3. Limited Awareness and Accessibility
      3. Opportunties
        1. Emerging Markets
        2. Expanding Applications
        3. Collaborations and Partnerships
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Interventional Oncology Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Embolization Devices
      2. Ablation Devices
      3. Support Devices
    2. Interventional Oncology Devices Market, By Procedure, 2021 - 2031 (USD Million)
      1. Thermal Tumor Ablation
      2. Non-thermal Tumor Ablation
      3. Transcatheter Arterial Chemoembolization (TACE)
      4. Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
      5. Transcatheter Arterial Embolization (TAE) or Bland Embolization
    3. Interventional Oncology Devices Market, By Cancer Type, 2021 - 2031 (USD Million)
      1. Liver Cancer
      2. Kidney Cancer
      3. Lung Cancer
      4. Bone Cancer
      5. Others
    4. Interventional Oncology Devices Market, By End Use, 2021 - 2031 (USD Million)

      1. Hospitals

      2. Ambulatory Surgical Centers

      3. Cancer Research Institutes

    5. Interventional Oncology Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Medtronic plc
      3. Terumo Corporation
      4. Merit Medical Systems, Inc
      5. Philips Volcano
  7. Analyst Views
  8. Future Outlook of the Market